QUEST Launches Supplier Improvement Program


By Maureen McKinney

April 22, 2008 | Premier, a hospital improvement group based in Charlotte, N.C., recently kicked off the QUEST Supplier Innovation Program aimed at testing and evaluating new technologies. The idea is to integrate suppliers into its existing QUEST performance initiative.

The program, which launched on April 15, will be open to any interested suppliers including IT vendors, pharmaceutical companies, and medical device manufacturers, explained Andy Brailo, Premier’s vice president of strategic accounts and co-chair of the supplier innovation program.

The new project is only one component of the larger QUEST: High Performing Hospitals Initiative, a three-year program that kicked off in January 2008. The hospital initiative includes a cohort of 150 providers. The overarching goal of the project, according to Meg Horgan, vice president for client services and QUEST project lead, is to move all of the hospitals into the top performance threshold in five categories: efficiency, mortality, patient experience, harm, and evidence-based care.

“We evaluate baseline performance in each hospital, and try to get them all in the bulls-eye in all five areas,” Horgan said. “There are hospitals with pockets of excellence, but we want them to be great across the board. This is large-scale collaborative that will allow them to share tools and best practices with one another.”

While developing the hospital improvement initiative, both Brailo and Horgan began to receive feedback from suppliers who wanted to participate in the project in some capacity. In response, they created the supplier innovation program as a way to provide the supplier community with an arena to test their products, as well as a way to utilize new technologies to help hospitals reach their target thresholds, said Brailo.

After interested vendors submit their detailed applications—complete with testimonials, white papers, and use cases—a subset of seven hospitals will narrow them down based on which interventions have the best chance of impacting quality of care. Once they have chosen a core group of “change concepts” to test, the seven charter members will advocate and solicit the involvement of member hospitals to pilot and validate them, Horgan said.

“It’s important that we’re not just testing in one area,” said Horgan. “One device might reduce costs, but we need to see if it will also reduce harm and increase efficiency.”

For instance, if the charter group chooses a medical device such as a catheter for testing, Horgan said, pilot hospitals must have a way to electronically capture its use—like a charge code—so that project managers can track its usage. After implementation, QUEST can then assess costs and number of urinary tract infections to determine how the device improves harm, efficiency, and cost of care, she added.

“These suppliers have actively solicited ways to get involved with the QUEST initiative, said Brailo. “They have been extremely enthusiastic, and it gives them an opportunity to do something that is less about their supply chain and more about improving patient outcomes.”

Participating hospitals also view the project as one way to potentially affect change in the industry, according to Horgan. In fact, QUEST’s advisory panel is a “who’s who of the industry, medical societies, and government groups,” and members of that panel have expressed interest in knowing which change concepts are effective, she said.

So far, 40 suppliers have submitted applications, and in order to be considered for the first phase of the project, submissions must be received by May 30.

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

SGI's Meeting Today’s Computational Needs for Science
The quest to better understand disease mechanisms and find new treatments is driven by new laboratory technologies and ever-more sophisticated modeling and simulation efforts. As such, life sciences R&D investigations increasingly are relying on more powerful computing resources. The challenge is how to accommodate the broad mix of applications.

Addressing this issue, this paper produced by the Bio-IT World Custom Publishing Group discusses a new SGI Hybrid Computing Environment approach. It optimally uses shared memory systems, multi-processor clusters, and FPGAs to accelerate computational workflows. Download This Free Paper



SGI's Supercharging Proteomics Discovery
The deeper study of proteins and their interactions can reveal scientific information once considered nearly untouchable to scientists and researchers. Today, unprecedented advancements in computing power are enabling the creation of mounds of proteomic based data along with the accompanying bottlenecks data can create.

Rather than just “simplify the experiment” to fit the computational resources an alternative is now available with the SGI Proteomics Appliance. This complimentary white paper, produced by the Bio-IT World Custom Publishing Group, looks at ways to use the Proteomic Appliance to handle the most intensive proteomics computing tasks facing science today. Download This Free Paper



Life Science Webcasts & Podcasts

Waters

Streamlining the Chromatographic Method Validation Process

Waters® Empower™ 2 Method Validation Manager (MVM) is a business-critical, compliant-ready software that reduces time and costs required to perform chromatographic method validation by as much as 80%. Learn in this podcast how MVM streamlines the method validation process and allows the entire process to be efficiently performed within Empower 2, so fewer software applications need be deployed, validated, and maintained. Download Now


More Podcasts

Job Openings

Lilly Singapore Center for Drug Discovery (LSCDD) - Associate Director of Informatics
Lead and mentor a strong team for the Bioinformatics group at the Integrative Computational Sciences (ICS) department at LSCDD towards the development of novel algorithms, data analysis methods and software tools for drug discovery. Work closely with the Software Engineering group at ICS, and collaborate with the Discovery IT organization in Europe and USA. For additional information, or to apply visit: LSCDD

Lilly Singapore Center for Drug Discovery (LSCDD) - Senior Software Engineer
Join a strong team of software engineers in our Integrative Computational Sciences (ICS) at LSCDD. Collaborate with, and help develop integrated applications to process and visualize data from cutting-edge technologies used by scientists at Lilly Research Labs (LRL) and the Drug Discovery Research (DDR) teams. The Software Engineering team provides computational tools and tailored software solutions that enable the global effort of Tailored Therapeutics; ‘The Right Drug, at The Right Dose for The Right Patient at The Right Time'. For additional information, or to apply visit: LSCDD

Related Resources & Products

Biomarker SOPs: Getting Optimum Value from Your Biomarker Program



For reprints and/or copyright permission, please contact RMS, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext 100 or via email to [email protected].